The FDA approved 2025-2026 COVID-19 vaccines for people 65 and older, and for younger people at high risk for severe COVID-19 infection.
The FDA approved 2025-2026 COVID-19 vaccines for people 65 and older, and for younger people at high risk for severe COVID-19 infection.